Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Genetic and clinical features of social cognition in 22q11.2 deletion syndrome.

Lattanzi GM, Buzzanca A, Frascarelli M, Di Fabio F.

J Neurosci Res. 2018 Oct;96(10):1631-1640. doi: 10.1002/jnr.24265. Epub 2018 Jul 13. Review.

PMID:
30004142
2.

Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.

Amin H, Marinaro F, De Pietri Tonelli D, Berdondini L.

Sci Rep. 2017 Nov 16;7(1):15752. doi: 10.1038/s41598-017-15793-9.

3.

Schizophrenia-Related Microdeletion Impairs Emotional Memory through MicroRNA-Dependent Disruption of Thalamic Inputs to the Amygdala.

Eom TY, Bayazitov IT, Anderson K, Yu J, Zakharenko SS.

Cell Rep. 2017 May 23;19(8):1532-1544. doi: 10.1016/j.celrep.2017.05.002.

4.

Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.

Thompson CA, Karelis J, Middleton FA, Gentile K, Coman IL, Radoeva PD, Mehta R, Fremont WP, Antshel KM, Faraone SV, Kates WR.

Am J Med Genet B Neuropsychiatr Genet. 2017 Apr;174(3):295-314. doi: 10.1002/ajmg.b.32515. Epub 2017 Jan 31.

PMID:
28139055
5.

Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.

Chun S, Du F, Westmoreland JJ, Han SB, Wang YD, Eddins D, Bayazitov IT, Devaraju P, Yu J, Mellado Lagarde MM, Anderson K, Zakharenko SS.

Nat Med. 2017 Jan;23(1):39-48. doi: 10.1038/nm.4240. Epub 2016 Nov 28.

6.

Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.

Lin M, Pedrosa E, Hrabovsky A, Chen J, Puliafito BR, Gilbert SR, Zheng D, Lachman HM.

BMC Syst Biol. 2016 Nov 15;10(1):105.

7.

Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.

Toyoshima M, Akamatsu W, Okada Y, Ohnishi T, Balan S, Hisano Y, Iwayama Y, Toyota T, Matsumoto T, Itasaka N, Sugiyama S, Tanaka M, Yano M, Dean B, Okano H, Yoshikawa T.

Transl Psychiatry. 2016 Nov 1;6(11):e934. doi: 10.1038/tp.2016.206.

8.

Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers.

Zhang X, Gee H, Rose B, Lee CS, Clark J, Elliott M, Gamble JR, Cairns MJ, Harris A, Khoury S, Tran N.

BMC Cancer. 2016 Feb 11;16:86. doi: 10.1186/s12885-016-2109-4.

9.

Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome.

Merico D, Zarrei M, Costain G, Ogura L, Alipanahi B, Gazzellone MJ, Butcher NJ, Thiruvahindrapuram B, Nalpathamkalam T, Chow EW, Andrade DM, Frey BJ, Marshall CR, Scherer SW, Bassett AS.

G3 (Bethesda). 2015 Sep 16;5(11):2453-61. doi: 10.1534/g3.115.021345.

10.

Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Napoli E, Tassone F, Wong S, Angkustsiri K, Simon TJ, Song G, Giulivi C.

J Biol Chem. 2015 Sep 18;290(38):23240-53. doi: 10.1074/jbc.M115.672360. Epub 2015 Jul 28.

11.

MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del.

Zhao D, Lin M, Chen J, Pedrosa E, Hrabovsky A, Fourcade HM, Zheng D, Lachman HM.

PLoS One. 2015 Jul 14;10(7):e0132387. doi: 10.1371/journal.pone.0132387. eCollection 2015.

12.

Comparative mapping of the 22q11.2 deletion region and the potential of simple model organisms.

Guna A, Butcher NJ, Bassett AS.

J Neurodev Disord. 2015;7(1):18. doi: 10.1186/s11689-015-9113-x. Epub 2015 Jul 1.

13.

Neuronal migration abnormalities and its possible implications for schizophrenia.

Muraki K, Tanigaki K.

Front Neurosci. 2015 Mar 10;9:74. doi: 10.3389/fnins.2015.00074. eCollection 2015. Review.

14.

MicroRNA Dysregulation, Gene Networks, and Risk for Schizophrenia in 22q11.2 Deletion Syndrome.

Merico D, Costain G, Butcher NJ, Warnica W, Ogura L, Alfred SE, Brzustowicz LM, Bassett AS.

Front Neurol. 2014 Nov 21;5:238. doi: 10.3389/fneur.2014.00238. eCollection 2014.

15.

Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome.

Sellier C, Hwang VJ, Dandekar R, Durbin-Johnson B, Charlet-Berguerand N, Ander BP, Sharp FR, Angkustsiri K, Simon TJ, Tassone F.

PLoS One. 2014 Aug 1;9(8):e103884. doi: 10.1371/journal.pone.0103884. eCollection 2014.

16.

Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models.

Chun S, Westmoreland JJ, Bayazitov IT, Eddins D, Pani AK, Smeyne RJ, Yu J, Blundon JA, Zakharenko SS.

Science. 2014 Jun 6;344(6188):1178-82. doi: 10.1126/science.1253895.

17.
18.

MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.

Forstner AJ, Degenhardt F, Schratt G, Nöthen MM.

Front Mol Neurosci. 2013 Dec 5;6:47. doi: 10.3389/fnmol.2013.00047. Review.

19.

Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model.

Toritsuka M, Kimoto S, Muraki K, Landek-Salgado MA, Yoshida A, Yamamoto N, Horiuchi Y, Hiyama H, Tajinda K, Keni N, Illingworth E, Iwamoto T, Kishimoto T, Sawa A, Tanigaki K.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17552-7. doi: 10.1073/pnas.1312661110. Epub 2013 Oct 7.

20.

The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion.

Fénelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA.

J Neurosci. 2013 Sep 11;33(37):14825-39. doi: 10.1523/JNEUROSCI.1611-13.2013.

Supplemental Content

Loading ...
Support Center